I had the pleasure of working with Steve for the past four years at Bayer. Steve's in-depth industry knowledge and experience coupled with a focus on delivering results is commendable. He collaboratively and diligently works developing short and long term multi-channel (trade and specialty) strategies integrating business insights and patient/customer perspectives into key decisions. I was impressed with his advanced business modeling and integration of work process flows to distill and simplify complex value propositions into integrated enterprise contracting strategies. We interacted frequently and he always shared the spotlight on collaborations when presented to leadership. He was and is a great mentor giving feedback and supporting areas for improvement. He is always a pleasure to be around with his thoughtful and engaging demeanor.

As US Brand Patient Marketing head, I led a time-sensitive & patient safety workstream to pivot our exclusively in-home Brand Patient Support Program, with the initial onset of Covid-19, towards a hybrid working model with both a remote & in-home exceptions option. The US Brand Team & I leaned heavy of Steve for his creativity, regulations insight & strategic commercial alignment to both patient & brand goals. While material program cost efficiencies were realized, this resulted without a loss in focus for patient-centric solutions. Thanks Steve for your valued contributions. 

Steve has been a true asset to the legal team in our assessment of various Market Access proposals. He has complete command over FMV assessments, but more importantly Steve has tremendous knowledge and experience in the Pharma access and distribution space. He explains scenarios in a digestible, understandable manner and comes to the discussion prepared to answer and offer solutions for anticipated compliance questions. An excellent collaboration partner and a colleague I can confidently recommend.